Tower Research Capital (TRC)’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.7K Buy
7,851
+3,560
+83% +$11.2K ﹤0.01% 3551
2025
Q1
$13.5K Sell
4,291
-1,586
-27% -$4.98K ﹤0.01% 3362
2024
Q4
$25.5K Buy
5,877
+1,180
+25% +$5.12K ﹤0.01% 3004
2024
Q3
$12.5K Sell
4,697
-28,021
-86% -$74.8K ﹤0.01% 3577
2024
Q2
$72.6K Buy
32,718
+29,313
+861% +$65.1K ﹤0.01% 2819
2024
Q1
$18.2K Buy
+3,405
New +$18.2K ﹤0.01% 3082
2023
Q4
Sell
-360
Closed -$500 5953
2023
Q3
$500 Buy
+360
New +$500 ﹤0.01% 5549
2023
Q2
Sell
-392
Closed -$1K 6048
2023
Q1
$1K Buy
392
+72
+23% +$184 ﹤0.01% 5511
2022
Q4
$0 Buy
+320
New ﹤0.01% 5947
2022
Q3
Sell
-388
Closed -$1K 6112
2022
Q2
$1K Sell
388
-24,028
-98% -$61.9K ﹤0.01% 5758
2022
Q1
$60K Buy
24,416
+21,421
+715% +$52.6K ﹤0.01% 2588
2021
Q4
$18K Sell
2,995
-9,185
-75% -$55.2K ﹤0.01% 3781
2021
Q3
$82K Sell
12,180
-6,837
-36% -$46K ﹤0.01% 2564
2021
Q2
$126K Buy
+19,017
New +$126K ﹤0.01% 2233
2021
Q1
Sell
-75
Closed -$1K 5434
2020
Q4
$1K Sell
75
-3,435
-98% -$45.8K ﹤0.01% 4980
2020
Q3
$50K Buy
+3,510
New +$50K ﹤0.01% 3540
2017
Q3
Sell
-74
Closed -$7K 3841
2017
Q2
$7K Sell
74
-540
-88% -$51.1K ﹤0.01% 1800
2017
Q1
$51K Buy
614
+595
+3,132% +$49.4K 0.01% 721
2016
Q4
$3K Buy
19
+4
+27% +$632 ﹤0.01% 3234
2016
Q3
$5K Hold
15
﹤0.01% 2526
2016
Q2
$5K Buy
+15
New +$5K ﹤0.01% 3355
2016
Q1
Sell
-27
Closed -$11K 4217
2015
Q4
$11K Sell
27
-17
-39% -$6.93K ﹤0.01% 1992
2015
Q3
$18K Buy
44
+7
+19% +$2.86K ﹤0.01% 1815
2015
Q2
$27K Hold
37
﹤0.01% 1835
2015
Q1
$18K Buy
37
+33
+825% +$16.1K ﹤0.01% 2329
2014
Q4
$1K Sell
4
-54
-93% -$13.5K ﹤0.01% 3616
2014
Q3
$19K Buy
+58
New +$19K ﹤0.01% 2334
2014
Q2
Sell
-72
Closed -$30K 4098
2014
Q1
$30K Sell
72
-74
-51% -$30.8K ﹤0.01% 1492
2013
Q4
$60K Buy
146
+110
+306% +$45.2K 0.01% 1238
2013
Q3
$19K Sell
36
-1
-3% -$528 ﹤0.01% 2719
2013
Q2
$19K Buy
+37
New +$19K ﹤0.01% 1756